|
Post by mydogskip on Jun 22, 2016 5:07:49 GMT -5
it seems a bit odd that Griffin would do this now just before the launch.
|
|
|
Post by patten1962 on Jun 22, 2016 6:08:46 GMT -5
Matt has done a great job. January when things looked very bad he had a plan and moved forward. Look at us today, 70 sales reps! 11 rn's. CCO Mike! Danbury running 2 shifts making Afrezza like crazy! They are making it for a reason. Longs, be strong. 5 years from now we can all be very wealthy! I agree with how quick they have moved with what appears to be a good plan. Though I don't before recall hearing or reading about 2 manufacturing shifts currently running.. Is this something that was perhaps mentioned at the shareholder's meeting? Yes it was. During the tour I asked how many shifts they were running. They said 2. That is a lot of product. I asked if I could see the warehouse so I could see the amount of product, they said no. Not allowed.
|
|
|
Post by LosingMyBullishness on Jun 22, 2016 7:43:44 GMT -5
So Wall Street, the shorts, SNY and your fellow bashers bear no responsibility? What nonsense. As for MannKind's management, they had no way of knowing that the Sanofi CEO who signed the Afrezza deal would be replaced by a CEO who would sandbag Afrezza. If that hadn't happened we'd be in good shape today. Normally you make a contract for the purpose of securing your own interests when things go wrong. Best example is a marriage contract. I often read that Al Mann had in mind to price Afrezza in line with other insulins and that he believes that SNY does it this way. They did not. They charged a significant premium. I am sure that Al Mann was very angry about this as it alone basically torpedoed the whole product start and MNKD itself. But how could they give the right away so entirely with no safety line? They were sitting in Valencia or Dansbury and watched the ship they built for so many years slowly sinking. It seems as if they were so 100% loyal to the contract that they not even had informal meeting with other companies for day X when they get the wreckage back from SNY. Sure the old management is to blame. Al was a great and visionary man and I have his "advice to a young man' on my computer desktop (although I am not young) but he was blind when it comes to the ethics of Big Pharma. And Hakan was , well, not the right person for the job. Still remember the horrible, horrible CCs. Anyway. Let's see how things evolve. Things look brighter now and hopefully one day we can leave this bunker and have nostalgic memories about this time.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 22, 2016 9:02:40 GMT -5
So Wall Street, the shorts, SNY and your fellow bashers bear no responsibility? What nonsense. As for MannKind's management, they had no way of knowing that the Sanofi CEO who signed the Afrezza deal would be replaced by a CEO who would sandbag Afrezza. If that hadn't happened we'd be in good shape today. Normally you make a contract for the purpose of securing your own interests when things go wrong. Best example is a marriage contract. I often read that Al Mann had in mind to price Afrezza in line with other insulins and that he believes that SNY does it this way. They did not. They charged a significant premium. I am sure that Al Mann was very angry about this as it alone basically torpedoed the whole product start and MNKD itself. But how could they give the right away so entirely with no safety line? They were sitting in Valencia or Dansbury and watched the ship they built for so many years slowly sinking. It seems as if they were so 100% loyal to the contract that they not even had informal meeting with other companies for day X when they get the wreckage back from SNY. Sure the old management is to blame. Al was a great and visionary man and I have his "advice to a young man' on my computer desktop (although I am not young) but he was blind when it comes to the ethics of Big Pharma. And Hakan was , well, not the right person for the job. Still remember the horrible, horrible CCs. Anyway. Let's see how things evolve. Things look brighter now and hopefully one day we can leave this bunker and have nostalgic memories about this time. Its sad because innovation and evolution are being road blocked by greed. I agree, I think Al, and all employees from MNKD were out of their league in the big pharma game. This is Game of Thrones with drugs, and they got a Grade A ass whopping. Hakan is not a CEO he is a scientist so I don't fault him. I fault those who thought he would be a good fit. Lets just hope the ass whopping that Matt has taken in the past 12 months has taught him something.
|
|
|
Post by kbrion77 on Jun 22, 2016 9:21:56 GMT -5
Normally you make a contract for the purpose of securing your own interests when things go wrong. Best example is a marriage contract. I often read that Al Mann had in mind to price Afrezza in line with other insulins and that he believes that SNY does it this way. They did not. They charged a significant premium. I am sure that Al Mann was very angry about this as it alone basically torpedoed the whole product start and MNKD itself. But how could they give the right away so entirely with no safety line? They were sitting in Valencia or Dansbury and watched the ship they built for so many years slowly sinking. It seems as if they were so 100% loyal to the contract that they not even had informal meeting with other companies for day X when they get the wreckage back from SNY. Sure the old management is to blame. Al was a great and visionary man and I have his "advice to a young man' on my computer desktop (although I am not young) but he was blind when it comes to the ethics of Big Pharma. And Hakan was , well, not the right person for the job. Still remember the horrible, horrible CCs. Anyway. Let's see how things evolve. Things look brighter now and hopefully one day we can leave this bunker and have nostalgic memories about this time. Its sad because innovation and evolution are being road blocked by greed. I agree, I think Al, and all employees from MNKD were out of their league in the big pharma game. This is Game of Thrones with drugs, and they got a Grade A ass whopping. Hakan is not a CEO he is a scientist so I don't fault him. I fault those who thought he would be a good fit. Lets just hope the ass whopping that Matt has taken in the past 12 months has taught him something. I agree with this. Unfortunately I'm sure MNKD had little to no leverage at the table with Sanofi because of their financial situation and Al's desire to partner with big pharma. Bad business decision and like you said they got b&*$# slapped for it. Time will tell if Matt and Team have it in them to build this thing. I would personally rather have DeSisto at the helm and was deflated when he backed out but maybe these new guys will surprise us. Hakan still on the payroll bothers me but who am I kidding this is corporate America.
|
|